MICHAEL R. DOUGHERTY - 01 Apr 2022 Form 4 Insider Report for IDERA PHARMACEUTICALS, INC.

Role
Director
Signature
/s/ Michael R. Dougherty
Issuer symbol
N/A
Transactions as of
01 Apr 2022
Net transactions value
+$22,018
Form type
4
Filing time
05 Apr 2022, 17:04:56 UTC
Previous filing
07 Feb 2022
Next filing
13 Jun 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction IDRA Common Stock Award $22,018 +41,155 +21% $0.5350 233,030 01 Apr 2022 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This stock was issued to the reporting person pursuant to his election, under the Issuer's director compensation program, to receive common stock in lieu of cash fees.